Rock Springs Capital Management LP - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 320 filers reported holding GW PHARMACEUTICALS PLC in Q4 2019. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rock Springs Capital Management LP ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q4 2020$13,755,000
+18.5%
119,1880.0%0.29%
-0.7%
Q3 2020$11,603,000
-21.2%
119,188
-0.7%
0.29%
-27.2%
Q2 2020$14,732,000
+460.8%
120,043
+300.1%
0.40%
+270.6%
Q1 2020$2,627,000
-76.0%
30,000
-68.4%
0.11%
-74.9%
Q3 2019$10,928,000
-89.5%
95,000
-84.3%
0.44%
-88.5%
Q2 2019$104,296,000
-11.6%
605,000
-13.6%
3.77%
-17.1%
Q1 2019$117,999,000
+102.1%
700,000
+16.8%
4.55%
+65.1%
Q4 2018$58,385,000
-15.5%
599,500
+49.9%
2.76%
+10.2%
Q3 2018$69,096,000
+12.5%
400,000
-9.1%
2.50%
+5.9%
Q2 2018$61,398,000
+51.4%
440,000
+22.2%
2.36%
+36.6%
Q1 2018$40,561,000
-13.2%
360,000
+1.7%
1.73%
-18.4%
Q4 2017$46,732,000
+23.4%
354,000
-5.1%
2.12%
+21.4%
Q3 2017$37,856,000
+3.3%
373,000
+2.1%
1.75%
-5.6%
Q2 2017$36,641,000
-15.0%
365,500
+2.5%
1.85%
-25.6%
Q1 2017$43,115,000
+8.4%
356,500
+0.1%
2.49%
-6.5%
Q4 2016$39,783,000
-7.8%
356,000
+9.5%
2.66%
-1.6%
Q3 2016$43,137,000
+74.5%
325,000
+20.4%
2.70%
+47.8%
Q2 2016$24,724,000
+133.1%
270,000
+83.7%
1.83%
+105.8%
Q1 2016$10,606,000
+31.7%
147,000
+26.7%
0.89%
+45.7%
Q4 2015$8,055,000
+3.1%
116,000
+35.7%
0.61%
-3.8%
Q3 2015$7,812,000
-13.2%
85,500
+16.7%
0.63%
-3.5%
Q2 2015$8,998,000
+41.1%
73,250
+4.6%
0.66%
+10.1%
Q1 2015$6,379,000
+236.6%
70,000
+150.0%
0.60%
+168.9%
Q4 2014$1,895,000
+79.8%
28,000
+57.7%
0.22%
-8.6%
Q1 2014$1,054,00017,7500.24%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q4 2019
NameSharesValueWeighting ↓
VHCP Management, LLC 311,853$25,213,00011.33%
Iguana Healthcare Management, LLC 50,000$4,043,0002.16%
Ghost Tree Capital, LLC 35,000$2,830,0001.54%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 354,278$28,643,0001.06%
Cupps Capital Management, LLC 100,213$8,102,0000.75%
CLOUGH CAPITAL PARTNERS L P 192,600$15,572,0000.58%
FARALLON CAPITAL MANAGEMENT LLC 244,000$19,727,0000.32%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 105,200$8,505,0000.31%
Eventide Asset Management 25,000$2,021,0000.28%
PRUDENTIAL PLC 836,124$67,601,0000.28%
View complete list of GW PHARMACEUTICALS PLC shareholders